Company intelligence / Profile preview

Bausch Health

Ownership: Public · BHC
Employees: ~19000
Development stage: Commercial

Overview

Bausch Health (formerly Valeant) is a global pharmaceutical company with a broad portfolio of over-the-counter and prescription drugs, mainly in dermatology, ophthalmology, neurology, and gastrointestinal areas. The company is known for commercializing acquired products rather than R&D innovation. There is no major recent clinical data; the company focuses on marketed portfolio management.

Modalities: Small moleculeBiologic
Industry: Biotech

Financials

Market cap: $3B
Total revenue: $10.3B
Enterprise value: $21.2B

Beyond the preview

Go deeper on Bausch Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bausch Health.